Biotech TV: Ross Barrett talks about a larger fund for investing in more companies, and shares technologies that excite him today.

Sep 27

Written by Mukul Verma

CFF

March Biosciences Closes Oversubscribed $28.4 Million Series A Financing

Eisbach Bio doses first patient in Phase 1/2 Trial for first-in-class drug to take on Refractory Advanced Solid Tumors